Tralokinumab |
| Catalog No.GC66350 |
Tralokinumab, un anticuerpo monoclonal IgG4 completamente humano, se une especÍficamente con alta afinidad a la IL-13 sola, lo que evita su interacciÓn con el receptor y la posterior seÑalizaciÓn posterior. Tralokinumab se puede utilizar para la investigaciÓn de la dermatitis atÓpica (DA).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1044515-88-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Tralokinumab, a fully human IgG4 monoclonal antibody, specifically binds with high affinity to IL-13 alone, preventing its interaction with the receptor and subsequent downstream signalling. Tralokinumab can be used for the research of the atopic dermatitis (AD)[1].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *